![](/img/cover-not-exists.png)
Natalizumab improves ambulation in relapsing−remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM
Voloshyna, N., Havrdová, E., Hutchinson, M., Nehrych, T., You, X., Belachew, S., Hotermans, C., Paes, D.Volume:
22
Language:
english
Journal:
European Journal of Neurology
DOI:
10.1111/ene.12618
Date:
March, 2015
File:
PDF, 306 KB
english, 2015